Assessing the impact of the president’s emergency plan for AIDS relief on all-cause mortality

• DOI: 10.1371/journal.pgph.0002467
• Publication Date: 2024-01-18T18:32:26Z
• Authors: Gary Gaumer; Yiqun Luan; Dhwani Hariharan; William Crown; Jennifer Kates; Monica Jordan; Clare L. Hurley; Allyala Nandakumar
• Keywords: Public aspects of medicine; RA1-1270; Research Article

This study estimated the impacts of PEPFAR on all-cause mortality (ACM) rates (deaths per 1,000 population) across recipient countries from 2004–2018. As moves into its 3rd decade, this supplements existing literature ‘s overall effectiveness in saving lives by focusing impact estimates important subgroups that received different intensities aid, and provides for phases 15-year period study. The uses a country-level panel data set 157 low- middle-income (LMICs) 1990–2018, including 90 receiving bilateral aid U.S. government, employing difference-in-differences (DID) econometric models with several model specifications, differing baseline covariates, yearly covariates other donor spending domestic health spending. Using five 10–21% decline ACM 2004 to 2018 is attributed presence group countries. Declines are somewhat larger (15–25%) those subject PEPFAR’s country operational planning (COP) process, where capita amounts largest (17–27%). Across we study, average be 7.6% reduction first 5-year (2004–2008), smaller second (5.5%) third (4.7%). In COP show decreases 7.4% PEPFAR, 7.7% reductions second, 6.6% third. correlated large declines rate, life-saving results persisted over time. effects PEFAR have been large, suggesting possibility spillover programming beyond HIV disease alone.